A new report from the International Air Transport Association, or IATA, predicts Europe's major carriers are on track to suffer $1.1 billion in net losses this year thanks to rising fuel costs.
That's the bad news. The good? A volatile oil market is forcing airlines to search for alternatives, and that means biofuels -- though in limited use today -- could become mainstream within a few years. No company stands to benefit more from this shift than Solazyme
Although there's plenty of technical expertise that goes into what Solayzme does, the simple explanation is that it specializes in turning microalgae into oil. And it can do so faster than alternatives and without the need for direct sunlight to act as a catalyzing agent.
Efficiency is what makes Solazyme's process disruptive, and could lead to a long-term solution for rising aircraft fuel costs. United Continental
A lot of big names with deep pockets have an interest in seeing Solazyme succeed. Honeywell
But if Europe is any indicator, demand from the major domestic and international air carriers will drive gains in the years ahead.
Just consider the numbers. IATA's loss estimates are pegged to oil staying at around $110 a barrel. Right now, with oil topping out at about $84 a barrel, that number looks conservative. Trouble is, IATA research shows that fuel still accounts for 33% of annual airline operating expenses, up from just 13%-14% a decade ago.
Something has to change. Either oil prices have to fall dramatically for the long term -- unlikely, in my view -- or carriers have to become more aggressive about developing alternatives. I'm betting on the latter in my CAPS portfolio, where you can see that I've picked Solazyme to outperform. I still like that call.
Searching for black gold
Solazyme is one of a handful of companies positioned to profit if oil prices surge over $100 a barrel again. In this free report, our senior analysts identify three more energy companies with multibagger potential. Find out more right now.
Fool contributor Tim Beyers is a member of the Motley Fool Rule Breakers stock-picking team and the Motley Fool Supernova Odyssey I mission. He didn't own shares in any of the companies mentioned in this article at the time of publication. Check out Tim's web home, portfolio holdings, and Foolish writings, or connect with him on Google+ or Twitter, where he goes by @milehighfool. You can also get his insights delivered directly to your RSS reader.
The Motley Fool owns shares of Solazyme. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.